Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

Plappert, H; Hobson-Merrett, C; Gibbons, B; Baker, E; Bevan, S; Clark, M; Creanor, S; Davies, L; Denyer, R; Frost, J; Gask, L; Gibson, J; Gill, L; Gwernan-Jones, R; Hardy, P; Hosking, J; Huxley, P; Jeffrey, A; Jones, B; Marwaha, S; Pinold, V; Planner, C; Rawcliffe, T; Reilly, S; Richards, D; Williams, L; Birchwood, M; Byng, R

COVID-19 Collection

Journal article

Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

Abstract:: BackgroundCurrent NHS policy encourages an integrated approach to provision of mental and physical care for individuals with long term mental health problems. The ‘PARTNERS2’ complex intervention is designed to support individuals with psychosis in a primary care setting.AimThe trial will evaluate the clinical and cost-effectiveness of the PARTNERS2 intervention.Design & settingThis is a cluster randomised controlled superiority trial comparing collaborative care (PARTNERS2) with usual care, with an internal pilot to assess feasibility. The setting will be primary care within four trial recruitment areas: Birmingham & Solihull, Cornwall, Plymouth, and Somerset. GP practices are randomised 1:1 to either (a) the PARTNERS2 intervention plus modified standard care (‘intervention’); or (b) standard care only (‘control’).MethodPARTNERS2 is a flexible, general practice-based, person-centred, coaching-based intervention aimed at addressing mental health, physical health, and social care needs. Two hundred eligible individuals from 39 GP practices are taking part. They were recruited through identification from secondary and primary care databases. The primary hypothesis is quality of life (QOL). Secondary outcomes include: mental wellbeing, time use, recovery, and process of physical care. A process evaluation will assess fidelity of intervention delivery, test hypothesised mechanisms of action, and look for unintended consequences. An economic evaluation will estimate its cost-effectiveness. Intervention delivery and follow-up have been modified during the COVID-19 pandemic.ConclusionThe overarching aim is to establish the clinical and cost-effectiveness of the model for adults with a diagnosis of schizophrenia, bipolar, or other types of psychoses

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Plappert, H., Hobson-Merrett, C., Gibbons, B., Baker, E., Bevan, S., Clark, M., Creanor, S., Davies, L., Denyer, R., Frost, J., Gask, L., Gibson, J., Gill, L., Gwernan-Jones, R., Hardy, P., Hosking, J., Huxley, P., Jeffrey, A., Jones, B., … Byng, R. (2021). Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial. British Journal of General Practice Open, 5(3), BJGPO.2021.0033-BJGPO.2021.0033.

MLA Style

Plappert, H, et al. “Evaluation of a Primary Care-Based Collaborative Care Model (PARTNERS2) for People with Diagnoses of Schizophrenia, Bipolar, or Other Psychoses: Study Protocol for a Cluster Randomised Controlled Trial.” British Journal of General Practice Open, vol. 5, no. 3, 2021, pp. BJGPO.2021.0033-BJGPO.2021.0033.

Chicago Style

Plappert, H, C Hobson-Merrett, B Gibbons, et al. 2021. “Evaluation of a Primary Care-Based Collaborative Care Model (PARTNERS2) for People with Diagnoses of Schizophrenia, Bipolar, or Other Psychoses: Study Protocol for a Cluster Randomised Controlled Trial.” British Journal of General Practice Open 5 (3): BJGPO.2021.0033-BJGPO.2021.0033.
Print